Issuance of Stock Acquisition Rights for Directors, Audit & Supervisory Board Members and Executive Officers
First written in FY2017-Q2. 9 of 16 entries say "Advanced", first in FY2017. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「The decrease of 83,000 shares in treasury common shares resulted from the exercise of stock options for 25,600 shares and the disposal of treasury shares as restricted stock compensation for 57,400 shares.」
There were exercises of rights for 25,600 shares under existing stock options, and 57,400 shares were disposed of under restricted stock compensation. - FY2025AdvancedAnnual report
「The decrease of 217,200 shares in treasury common shares resulted from the exercise of stock options for 170,800 shares and the disposal of treasury shares as restricted stock compensation for 46,400 shares.」
There were exercises covering 170,800 shares under previously issued stock options, resulting in further utilisation of those options. - FY2025-H1Exercise of existing stock acquisition rightsAnnual report
「Treasury shares decreased by 8,000 shares as a result of the disposal of treasury shares following the exercise of stock options effective 26 September 2024, but the impact of that disposal of treasury shares has not been taken into account.」
Although no new stock acquisition rights were issued, the Company reports the disposal of 8,000 treasury shares following the exercise of stock options effective 26 September 2024. - FY2023-Q1DroppedAnnual report
「Not applicable.」
The Company states that no stock acquisition rights or other similar rights were issued during the current first quarter. - FY2021DroppedAnnual report
「Following approval of the proposal concerning the determination of compensation for the allocation of restricted shares at the 58th Annual General Meeting of Shareholders held on 18 June 2021, the Company decided that no further stock acquisition rights would be allocated as stock options linked to share-based compensation, other than those already allocated.」
The Company changed its policy so that no new allocations of stock options linked to share-based compensation would be made, except for existing stock acquisition rights. - FY2021-Q2RestatedAnnual report
「Resolution date 15 July 2020 Categories and number of persons eligible for grants 5 Company directors, excluding outside directors 9 Company executive officers Number of stock acquisition rights * 234 Class, terms and number of underlying shares * 93,600 common shares (Note 1)」
The Company continues to report the 234 stock acquisition rights representing 93,600 underlying shares granted to directors and executive officers based on the resolution dated 15 July 2020. - FY2021-Q1AdvancedAnnual report
「Resolution date 15 July 2020 Categories and number of persons eligible for grants 5 Company directors, excluding outside directors 9 Company executive officers Number of stock acquisition rights * 234 Class, terms and number of underlying shares * 93,600 common shares (Note 1)」
Based on the resolution dated 15 July 2020, 234 stock acquisition rights representing 93,600 underlying shares were allocated to 5 directors and 9 executive officers. - FY2020AdvancedAnnual report
「The decrease of 139,600 shares in treasury common shares resulted from the exercise of stock options.」
During the fiscal year, 139,600 shares under previously issued stock options were exercised, resulting in further utilisation of those options. - FY2020-Q2RestatedAnnual report
「Resolution date: 12 July 2019 Categories and number of persons eligible for grants: 6 Company directors, excluding outside directors; 8 Company executive officers Number of stock acquisition rights: 236 Class, terms and number of underlying shares: 94,400 common shares」
The Company continues to report the 236 stock acquisition rights representing 94,400 underlying shares allocated to directors and executive officers on 30 July 2019. - FY2020-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 12 July 2019, the Company resolved the offering terms for stock acquisition rights to be issued as stock options to its directors and executive officers, and resolved to solicit subscriptions from persons who would subscribe for the stock acquisition rights and related matters.」
Based on the resolution dated 12 July 2019, 236 stock acquisition rights representing 94,400 underlying shares were allocated on 30 July to 6 directors and 8 executive officers. - FY2019AdvancedAnnual report
「The decrease of 18,400 shares in treasury common shares resulted from the exercise of stock options.」
During the fiscal year, 18,400 shares under previously issued stock options were exercised, resulting in further utilisation of those options. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 13 July 2018, the Company resolved the offering terms for stock acquisition rights to be issued as stock options to its directors and executive officers, and resolved to solicit subscriptions from persons who would subscribe for the stock acquisition rights and related matters.」
Based on the resolution and allocation in July 2018, the Company made concrete progress by issuing 171 stock acquisition rights representing 68,400 underlying shares to directors and executive officers. - FY2018RestatedAnnual report
「31 July 2017 Board of Directors' resolution」
The Company continues to report, in its stock option disclosures for the full fiscal year, that 83,200 shares were granted under the sixth series of stock acquisition rights to 8 directors and 6 executive officers. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the current second-quarter accounting period are as follows. Number of stock acquisition rights 208 (Note 1) Number of underlying shares 83,200 shares (Note 1) Amount payable upon exercise of stock acquisition rights ¥1 per share」
Based on a resolution dated 31 July 2017, the Company issued 208 stock acquisition rights representing 83,200 underlying shares to directors, statutory auditors, executive officers and others. - FY2017AdvancedAnnual report
「Exercise 42,000 26,800」
During the fiscal year, 42,000 shares under the first series of stock acquisition rights and 26,800 shares under the second series were exercised, resulting in further utilisation of previously issued stock options. - FY2017-Q2First statedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The Company issued 248 stock acquisition rights representing 99,200 underlying shares. The exercise price was ¥1 per share, and the exercise period was from 17 August 2016 to 16 August 2046. The terms provide for conditions on exercise after the holder ceases to hold the position of director, statutory auditor, executive officer or other specified position.